Targeting Tyro3 ameliorates a model of PGRN-mutant FTLD-TDP via tau-mediated synaptic pathology.
about
Targeting Tyro3 ameliorates a model of PGRN-mutant FTLD-TDP via tau-mediated synaptic pathology.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Targeting Tyro3 ameliorates a ...... u-mediated synaptic pathology.
@en
Targeting Tyro3 ameliorates a ...... u-mediated synaptic pathology.
@nl
type
label
Targeting Tyro3 ameliorates a ...... u-mediated synaptic pathology.
@en
Targeting Tyro3 ameliorates a ...... u-mediated synaptic pathology.
@nl
prefLabel
Targeting Tyro3 ameliorates a ...... u-mediated synaptic pathology.
@en
Targeting Tyro3 ameliorates a ...... u-mediated synaptic pathology.
@nl
P2093
P2860
P1476
Targeting Tyro3 ameliorates a ...... au-mediated synaptic pathology
@en
P2093
Ayumu Saito
Hidenori Homma
Hiroyasu Akatsu
Hitoshi Okazawa
Kazuhiko Tagawa
Kozo Kaibuchi
Kyota Fujita
Satoru Miyano
Xigui Chen
Yoshio Hashizume
P2860
P2888
P356
10.1038/S41467-018-02821-Z
P407
P577
2018-01-30T00:00:00Z